查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595146

PCR 技术市场：按技术、产品类型、应用和最终用户划分 - 2025-2030 年全球预测

PCR Technologies Market by Technique (Conventional PCR, Digital PCR, Hot-Start PCR), Product Type (Instruments, Reagents & Consumables, Software & Services), Application, End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

根据预测，2023年PCR技术市值为49.8亿美元，预计到2024年将达到54.3亿美元，复合年增长率为9.64%，到2030年将达到94.9亿美元。

聚合酵素链锁反应（PCR）技术作为扩增DNA序列的重要工具，在分子诊断市场中涵盖广泛。对于研究、法医学、医疗诊断和生物防御等各种应用至关重要。 PCR 的需求至关重要，因为它速度快、准确性高，并且能够处理最少的 DNA 样本，从而可以进行详细的遗传分析，有助于疾病检测、个人化医疗和遗传研究。最终用途包括临床实验室、医院、学术机构、生技公司等。 PCR技术市场的主要成长要素包括基因组研究的进步、感染疾病的流行以及精准医疗需求的不断增长。最近的趋势强调将 PCR 与数位和就地检验相结合，以增强快速诊断。 COVID-19 大流行加速了 PCR 技术在病毒识别中的关键作用，并创造了新的机会，例如可携式PCR 设备的开发。然而，挑战包括高成本、技术复杂性以及次世代定序等替代技术的出现。此外，潜在的监管障碍和对技术人员的需求也构成了进一步的限制。 PCR 技术的创新可能会扩大应用范围，重点是提高灵敏度和速度、降低成本以及用于资料分析的人工智慧整合。儘管市场仍然竞争激烈，但对于专注于利基应用或开发用户友好且经济高效的解决方案来提高可访问性的参与企业来说，时机已经成熟。鼓励希望在个人化医疗和感染疾病控制领域抓住新商机的公司投资于策略联盟和研发。儘管 PCR 技术不断发展，有望简化工作流程并提高效率，相关人员必须应对竞争压力和监管环境。促进创新非常重要，市场趋势是自动化流程和简化 PCR 应用，以扩展其在不同领域的范围和效用。

主要市场统计
基准年[2023] 49.8亿美元
预测年份 [2024] 54.3亿美元
预测年份 [2030] 94.9亿美元
复合年增长率（%） 9.64%

市场动态：揭示快速发展的 PCR 技术市场的关键市场洞察

PCR 技术市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球严重增加
    • 政府对研发的支持
    • 实时定量 PCR (RT-qPCR) 在研究中的应用增加
    • 在法医部门中非常重要
  • 市场限制因素
    • 假阴性和再感染的可能性
  • 市场机会
    • 诊断中心和医院数量的增加
    • 基于基因组的药物发现方法的兴起
    • COVID-19 导致 RT-PCR 快速成长
  • 市场挑战
    • 替代测试的可用性
    • 缺乏保险报销政策

波特五力：驾驭 PCR 技术市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解PCR技术市场的外部影响

外部宏观环境因素在塑造PCR技术市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解PCR技术市场的竞争状况

PCR 技术市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵PCR技术市场供应商绩效评估

FPNV定位矩阵是评估PCR技术市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

制定 PCR 技术市场成功之路的策略分析和建议

PCR 技术市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地严重的发生率上升
      • 政府对研发的支持
      • 实时定量 PCR (RT-qPCR) 在研究中的应用不断增加
      • 在法医学部门中非常重要
    • 抑制因素
      • 假阴性和可能的​​再感染
    • 机会
      • 诊断中心和医院数量的增加
      • 基于基因组的药物发现方法的兴起
      • 由于 COVID-19，RT-PCR 迅速增加
    • 任务
      • 替代测试的可用性
      • 缺乏支持性报销政策
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 PCR 技术市场：依技术分类

  • 常规PCR
  • 数位PCR
  • 热启动PCR
  • 多重PCR
  • 即时PCR
  • 逆转录聚合酶连锁反应

第七章 PCR 技术市场：依产品类型

  • 装置
  • 试剂/耗材
  • 软体和服务

第八章 PCR 技术市场：依应用分类

  • 诊断应用
  • 环境应用
  • 基因表现分析
  • 基因序列分析
  • 基因型鉴定
  • 核酸检测
  • 核酸合成
  • 标准检验/检验

第 9 章 PCR 技术市场：依最终用户分类

  • 学术和政府机构
  • 应用产业
  • 医疗保健产业
  • 医院和诊断中心
  • 製药生物技术公司

第十章 美洲PCR技术市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区PCR技术市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲PCR技术市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Analytik Jena GmbH
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Danaher Corporation
  • Eppendorf SE
  • F. Hoffmann-La Roche Ltd.
  • Fluidigm Corporation by Standard BioTools Inc.
  • Merck KGaA
  • Promega Corporation
  • Qiagen NV
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-FD3F12D53D2D

The PCR Technologies Market was valued at USD 4.98 billion in 2023, expected to reach USD 5.43 billion in 2024, and is projected to grow at a CAGR of 9.64%, to USD 9.49 billion by 2030.

Polymerase Chain Reaction (PCR) Technologies have a broad scope within the molecular diagnostics market, serving as a crucial tool for amplifying DNA sequences. It's integral in various applications like research, forensics, medical diagnostics, and biodefense. PCR's necessity is paramount for its speed, accuracy, and capacity to work with minimal DNA samples, enabling detailed genetic analysis that aids in disease detection, personalized medicine, and genetic research. End-use includes clinical laboratories, hospitals, academic institutions, and biotech companies. Key growth factors in the PCR technology market involve advancements in genome studies, growing prevalence of infectious diseases, and escalating demand for precision medicine. Recent trends highlight the integration of PCR with digital and point-of-care testing, enhancing rapid diagnostics. The COVID-19 pandemic has accelerated PCR technology adoption due to its critical role in identifying the virus, spawning new opportunities like the development of portable PCR devices. However, challenges include high costs, technical complexities, and the advent of alternate technologies such as next-generation sequencing. Furthermore, potential regulatory hurdles and the need for skilled personnel pose added constraints. Innovations in PCR technology could focus on improving sensitivity and speed, reducing costs, and integrating AI for data analysis to expand applications. The market remains competitive but ripe for entrants focusing on niche applications or developing user-friendly, cost-efficient solutions that enhance accessibility. Strategic collaborations and investments in R&D are recommended for companies aiming to capture emerging opportunities in personalized medicine and infectious disease control. While PCR technology continues to evolve with advancements promising to streamline workflows and increase efficiency, stakeholders must navigate competitive pressures and regulatory landscapes. Fostering innovation is crucial, with a market inclination towards automating processes and simplifying PCR applications to broaden its scope and utility across diverse sectors.

KEY MARKET STATISTICS
Base Year [2023] USD 4.98 billion
Estimated Year [2024] USD 5.43 billion
Forecast Year [2030] USD 9.49 billion
CAGR (%) 9.64%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving PCR Technologies Market

The PCR Technologies Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidences of critical diseases across the world
    • Government support for R&D
    • Rise in Real-time Quantitative PCR (RT-qPCR) application in research
    • High importance in forensics department
  • Market Restraints
    • False negatives and reinfections possibilities
  • Market Opportunities
    • Growth in number of diagnostic centers and hospitals
    • Rising approach towards genome-based drug discovery
    • Rapid growth in RT-PCR due to COVID-19
  • Market Challenges
    • Availability of alternative test
    • Lack of supportive reimbursement policies

Porter's Five Forces: A Strategic Tool for Navigating the PCR Technologies Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the PCR Technologies Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the PCR Technologies Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the PCR Technologies Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the PCR Technologies Market

A detailed market share analysis in the PCR Technologies Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the PCR Technologies Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the PCR Technologies Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the PCR Technologies Market

A strategic analysis of the PCR Technologies Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the PCR Technologies Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Analytik Jena GmbH, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Danaher Corporation, Eppendorf SE, F. Hoffmann-La Roche Ltd., Fluidigm Corporation by Standard BioTools Inc., Merck KGaA, Promega Corporation, Qiagen N.V., Takara Bio, Inc., and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the PCR Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technique, market is studied across Conventional PCR, Digital PCR, Hot-Start PCR, Multiplex PCR, Real-Time PCR, and Reverse Transcription PCR.
  • Based on Product Type, market is studied across Instruments, Reagents & Consumables, and Software & Services.
  • Based on Application, market is studied across Diagnostic Applications, Environmental Applications, Gene Expression Analysis, Genetic Sequencing, Genotyping, Nucleic Acid Detection, Nucleic Acid Synthesis, and Standard Validation/Verification.
  • Based on End-user, market is studied across Academia & Government Organizations, Applied Industries, Healthcare Industry, Hospitals & Diagnostic Centers, and Pharma-Biotech Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of critical diseases across the world
      • 5.1.1.2. Government support for R&D
      • 5.1.1.3. Rise in Real-time Quantitative PCR (RT-qPCR) application in research
      • 5.1.1.4. High importance in forensics department
    • 5.1.2. Restraints
      • 5.1.2.1. False negatives and reinfections possibilities
    • 5.1.3. Opportunities
      • 5.1.3.1. Growth in number of diagnostic centers and hospitals
      • 5.1.3.2. Rising approach towards genome-based drug discovery
      • 5.1.3.3. Rapid growth in RT-PCR due to COVID-19
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative test
      • 5.1.4.2. Lack of supportive reimbursement policies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. PCR Technologies Market, by Technique

  • 6.1. Introduction
  • 6.2. Conventional PCR
  • 6.3. Digital PCR
  • 6.4. Hot-Start PCR
  • 6.5. Multiplex PCR
  • 6.6. Real-Time PCR
  • 6.7. Reverse Transcription PCR

7. PCR Technologies Market, by Product Type

  • 7.1. Introduction
  • 7.2. Instruments
  • 7.3. Reagents & Consumables
  • 7.4. Software & Services

8. PCR Technologies Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostic Applications
  • 8.3. Environmental Applications
  • 8.4. Gene Expression Analysis
  • 8.5. Genetic Sequencing
  • 8.6. Genotyping
  • 8.7. Nucleic Acid Detection
  • 8.8. Nucleic Acid Synthesis
  • 8.9. Standard Validation/Verification

9. PCR Technologies Market, by End-user

  • 9.1. Introduction
  • 9.2. Academia & Government Organizations
  • 9.3. Applied Industries
  • 9.4. Healthcare Industry
  • 9.5. Hospitals & Diagnostic Centers
  • 9.6. Pharma-Biotech Companies

10. Americas PCR Technologies Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific PCR Technologies Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa PCR Technologies Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Agilent Technologies, Inc.
  • 3. Analytik Jena GmbH
  • 4. Becton, Dickinson and Company
  • 5. Bio-Rad Laboratories, Inc.
  • 6. bioMerieux SA
  • 7. Danaher Corporation
  • 8. Eppendorf SE
  • 9. F. Hoffmann-La Roche Ltd.
  • 10. Fluidigm Corporation by Standard BioTools Inc.
  • 11. Merck KGaA
  • 12. Promega Corporation
  • 13. Qiagen N.V.
  • 14. Takara Bio, Inc.
  • 15. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. PCR TECHNOLOGIES MARKET RESEARCH PROCESS
  • FIGURE 2. PCR TECHNOLOGIES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PCR TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES PCR TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES PCR TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. PCR TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. PCR TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PCR TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PCR TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PCR TECHNOLOGIES MARKET DYNAMICS
  • TABLE 7. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY CONVENTIONAL PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY HOT-START PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY GENETIC SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY GENOTYPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY NUCLEIC ACID DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY NUCLEIC ACID SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY STANDARD VALIDATION/VERIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY ACADEMIA & GOVERNMENT ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY APPLIED INDUSTRIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY HEALTHCARE INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY PHARMA-BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES PCR TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. MALAYSIA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. PHILIPPINES PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 89. PHILIPPINES PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. PHILIPPINES PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SINGAPORE PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 93. SINGAPORE PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SINGAPORE PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SINGAPORE PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. SOUTH KOREA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 97. SOUTH KOREA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. SOUTH KOREA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. SOUTH KOREA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. TAIWAN PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 101. TAIWAN PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. TAIWAN PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. TAIWAN PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. THAILAND PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 105. THAILAND PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. THAILAND PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. THAILAND PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. VIETNAM PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 109. VIETNAM PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. VIETNAM PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. VIETNAM PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA PCR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 117. DENMARK PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 118. DENMARK PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. DENMARK PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. DENMARK PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. EGYPT PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 122. EGYPT PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. EGYPT PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. EGYPT PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. FINLAND PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 126. FINLAND PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. FINLAND PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. FINLAND PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. FRANCE PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 130. FRANCE PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. FRANCE PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. FRANCE PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. GERMANY PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 134. GERMANY PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. GERMANY PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. GERMANY PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. ISRAEL PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 138. ISRAEL PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. ISRAEL PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. ISRAEL PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. ITALY PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 142. ITALY PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. ITALY PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. ITALY PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. NETHERLANDS PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 146. NETHERLANDS PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NETHERLANDS PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. NETHERLANDS PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. NIGERIA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 150. NIGERIA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. NIGERIA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. NIGERIA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. NORWAY PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 154. NORWAY PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. NORWAY PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. NORWAY PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. POLAND PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 158. POLAND PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. POLAND PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. POLAND PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. QATAR PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 162. QATAR PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. QATAR PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. QATAR PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. RUSSIA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 166. RUSSIA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. RUSSIA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. RUSSIA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SAUDI ARABIA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 170. SAUDI ARABIA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SAUDI ARABIA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SAUDI ARABIA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH AFRICA PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH AFRICA PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH AFRICA PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SOUTH AFRICA PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. SPAIN PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 178. SPAIN PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SPAIN PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. SPAIN PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. SWEDEN PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 182. SWEDEN PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. SWEDEN PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. SWEDEN PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. SWITZERLAND PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 186. SWITZERLAND PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. SWITZERLAND PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. SWITZERLAND PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. TURKEY PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 190. TURKEY PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. TURKEY PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. TURKEY PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED ARAB EMIRATES PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED ARAB EMIRATES PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED ARAB EMIRATES PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED ARAB EMIRATES PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED KINGDOM PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 198. UNITED KINGDOM PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. UNITED KINGDOM PCR TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. UNITED KINGDOM PCR TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. PCR TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 202. PCR TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023